tradingkey.logo
搜尋

Heartflow Inc

HTFL
添加自選
28.315USD
-3.925-12.17%
收盤 05/15, 16:00美東報價延遲15分鐘
2.44B總市值
虧損本益比TTM

Heartflow Inc

28.315
-3.925-12.17%

關於 Heartflow Inc 公司

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc簡介

公司代碼HTFL
公司名稱Heartflow Inc
上市日期Aug 08, 2025
CEOFarquhar (John C. M)
員工數量699
證券類型Ordinary Share
年結日Aug 08
公司地址331 E Evelyn Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94041
電話16502411221
網址https://www.heartflow.com/
公司代碼HTFL
上市日期Aug 08, 2025
CEOFarquhar (John C. M)

Heartflow Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
3.19M
+99.48%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
246.26K
--
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
130.21K
-1.54%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
3.19M
+99.48%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
246.26K
--
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
130.21K
-1.54%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2024
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United states
162.73M
92.44%
Rest of the world
13.30M
7.56%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 5月14日 週四
更新時間: 5月14日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Wellington Management Company, LLP
13.82%
Bain Capital Life Sciences Investors, LLC
9.80%
Fidelity Management & Research Company LLC
4.66%
Tansey (Casey M)
3.70%
Baron Capital Management, Inc.
2.67%
其他
65.35%
持股股東
持股股東
佔比
Wellington Management Company, LLP
13.82%
Bain Capital Life Sciences Investors, LLC
9.80%
Fidelity Management & Research Company LLC
4.66%
Tansey (Casey M)
3.70%
Baron Capital Management, Inc.
2.67%
其他
65.35%
股東類型
持股股東
佔比
Investment Advisor
41.91%
Investment Advisor/Hedge Fund
23.87%
Individual Investor
5.19%
Hedge Fund
4.55%
Research Firm
0.31%
Bank and Trust
0.30%
Venture Capital
0.18%
Pension Fund
0.09%
Private Equity
0.04%
其他
23.55%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
129
59.51M
43.48%
--
2026Q1
237
65.02M
75.47%
+2.36M
2025Q4
157
60.44M
71.29%
+22.15M
2025Q3
46
45.42M
54.46%
+42.91M

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Wellington Management Company, LLP
11.92M
13.9%
+6.03M
+102.26%
Feb 27, 2026
Bain Capital Life Sciences Investors, LLC
10.45M
12.18%
-2.00M
-16.07%
Feb 04, 2026
Fidelity Management & Research Company LLC
4.02M
4.69%
-598.27K
-12.95%
Dec 31, 2025
Baron Capital Management, Inc.
2.30M
2.69%
+1.07M
+86.17%
Dec 31, 2025
HealthCor Partners Management LP
6.70M
7.81%
--
--
Dec 31, 2025
Schusterman Interests LLC
1.94M
2.26%
--
--
Dec 31, 2025
Capricorn Investment Group LLC
1.66M
1.94%
-2.26M
-57.64%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
佔比3.13%
Global X HealthTech ETF
佔比1.75%
Fidelity Blue Chip Growth ETF
佔比0.07%
T Rowe Price Small-Mid Cap ETF
佔比0.06%
iShares Health Innovation Active ETF
佔比0.02%
Schwab U.S. Small-Cap ETF
佔比0.02%
Fidelity Nasdaq Composite Index ETF
佔比0.01%
Schwab U.S. Broad Market ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI